• If you are wondering whether Synopsys at around US$397.90 is priced for opportunity or already reflects high expectations, the key is to focus on what current valuation metrics are actually saying.
• The stock has seen a mixed run, with a 0.4% return over the last 7 days, a 9.0% decline over the past 30 days, a 17.2% decline year to date, but a 4.3% gain over the past year.
• These moves sit against a backdrop of ongoing interest in semiconductor design tools, AI related software and broader software names. This can influence how investors think about risk and potential returns. Sector sentiment, regulation around advanced chips and changing capital allocation priorities across technology companies are all part of the backdrop for Synopsys right now.
• Simply Wall St currently gives Synopsys a value score of 1 out of 6. This sets up a closer look at how different valuation approaches stack up and hints at a more complete way to think about value that will be covered at the end of this article.

Synopsys scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Synopsys Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model takes forecasts of a company’s future cash flows, then discounts them back to today’s terms to estimate what the business could be worth right now.

For Synopsys, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow stands at about US$2.24b. Based on a blend of analyst inputs for the next few years and Simply Wall St extrapolations further out, free cash flow is projected to reach about US$4.56b by 2030.

Those annual cash flows, including ten year projections from 2026 to 2035, are discounted back to the present using a required rate of return. Adding these discounted amounts together gives an estimated intrinsic value of around US$396.11 per share.

Against a current share price of about US$397.90, the DCF output suggests Synopsys trades at roughly a 0.5% premium to this estimate, which effectively points to a price that is very close to the modelled value.

Result: ABOUT RIGHT

Synopsys is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Synopsys.

Approach 2: Synopsys Price vs Earnings

For a profitable company like Synopsys, the P/E ratio is a useful way to connect what you pay for each share with the earnings that support it. It helps you see how many dollars investors are currently willing to pay for one dollar of annual earnings.

What counts as a “normal” or “fair” P/E depends on how investors view a company’s growth potential and risks. Higher expected growth or lower perceived risk can support a higher P/E, while lower growth or higher risk usually point to a lower, more cautious multiple.

Synopsys currently trades on a P/E of about 68.96x. That is well above the Software industry average P/E of about 30.13x and above the peer average of around 38.32x. Simply Wall St’s Fair Ratio for Synopsys is 43.64x, which is its proprietary view of what the P/E could be given factors such as earnings growth, profit margins, industry, market cap and risk profile.

This Fair Ratio goes further than a basic peer or industry comparison because it is tailored to Synopsys’ own fundamentals rather than broad sector averages. Compared to the current P/E of 68.96x, the Fair Ratio of 43.64x points to the shares trading above that modelled level.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your Synopsys Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives are introduced here as short, clear stories you choose about Synopsys that connect your view on its opportunities and risks to specific forecasts for revenue, earnings and margins. The Simply Wall St Community page then turns these into a Fair Value you can compare with the current price to help you decide whether Synopsys looks cheap or expensive based on your view. It automatically refreshes that view when new earnings or news arrive, and lets different investors sit anywhere between a cautious narrative that lines up closer to the lower analyst fair value of about US$425 and a more optimistic narrative closer to the higher fair value of around US$650, all using the same easy tool that is already used by millions of investors on the platform.

Do you think there's more to the story for Synopsys? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.